Leqembi
Submitted by Anonymous (not verified) on 14 October 2025 - 10:35
Leqembi
Refresher training webinar on post-authorisation procedure management in IRIS for marketing authorisation holders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 10:00 (CEST) to 30 September 2025, 12:00 (CEST)
Submitted by Anonymous (not verified) on 14 October 2025 - 10:16
Refresher training webinar on post-authorisation procedure management in IRIS for marketing authorisation holders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 10:00 (CEST) to 30 September 2025, 12:00 (CEST)
Quetiapine
Submitted by Anonymous (not verified) on 14 October 2025 - 10:10
Quetiapine
Management Board - Outcome of written procedures finalised during the period from 29 June to 22 September 2025
Submitted by Anonymous (not verified) on 14 October 2025 - 9:37
Management Board - Outcome of written procedures finalised during the period from 29 June to 22 September 2025
Agenda - Medicine Shortages (SPOC) Working Party meeting on 14-15 October 2025
Submitted by Anonymous (not verified) on 14 October 2025 - 9:11
Agenda - Medicine Shortages (SPOC) Working Party meeting on 14-15 October 2025
Agenda - PDCO agenda of the 14-17 October 2025 meeting
Submitted by Anonymous (not verified) on 14 October 2025 - 9:04
Agenda - PDCO agenda of the 14-17 October 2025 meeting
Timetable: Type II variation and worksharing application monthly assessment
Submitted by Anonymous (not verified) on 14 October 2025 - 9:01
Timetable: Type II variation and worksharing application monthly assessment
Timetable: Type II variation and worksharing application alternative monthly assessment
Submitted by Anonymous (not verified) on 14 October 2025 - 9:01
Timetable: Type II variation and worksharing application alternative monthly assessment
Timetable: Post-authorisation measure (PAM) assessed by PRAC
Submitted by Anonymous (not verified) on 14 October 2025 - 9:00
Timetable: Post-authorisation measure (PAM) assessed by PRAC
Respiporc Flu3 : EPAR - Medicine overview
Submitted by Anonymous (not verified) on 14 October 2025 - 9:00
Respiporc Flu3 : EPAR - Medicine overview